Navigation Links
Photos: Breakthrough Technology Enables Edible TruTag(TM) to Prevent Counterfeit Medicine
Date:5/26/2009

HONOLULU, May 26 /PRNewswire/ -- Cellular Bioengineering, Inc. (CBI) announces it is developing a novel technology that can help prevent not only counterfeit medicine and other consumables, but can also be used in a wide range of often-counterfeit goods from airplane parts, great works of art, currency, electronic components, high value added ingredients, to cosmetics and luxury goods.

To view the Multimedia News Release go to: http://www.prnewswire.com/mnr/trutag/38547/

(Photo: http://www.newscom.com/cgi-bin/prnh/20090526/NY21951 )

CBI's TruTag(TM) presents a breakthrough in the fight against counterfeit medicine, food, and consumer goods. The tags are made of the highest purity silica, rendering them biologically inert and edible. Each tag contains a custom-manufactured 'spectral signature' chosen from over one trillion possibilities. The unique choice of tag signature and product combination is the TruTag(TM) key to confirming the authenticity of the product, yet each tag costs less than a penny.

"The ability to authenticate and track individual pills is an exciting and potentially valuable tool in the effort to fight counterfeit pharmaceuticals," said Paul Kocher, Founder and Chief Scientist, Cryptography Research, Inc. "I believe CBI is breaking ground on a new modality of safety, assurance and information essential for consumers and the U.S. Government," said Admiral Thomas Fargo USN (Ret), Former Commander U.S. Pacific Command. "This project has the potential to save lives and make a significant contribution towards the safety and authentication of wide ranging goods and
'/>"/>

SOURCE Cellular Bioengineering Inc. (CBI)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Photos: Project Runways Tim Gunn Launches Addressing Psoriasis(TM) Campaign to Advocate That Patients Shouldnt Let Psoriasis Impact Personal Style
2. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
5. Kingfisher Healthcare Launches Breakthrough Product in Europe
6. New technique can be breakthrough for early cancer diagnosis
7. Breakthrough research identifies how cells from pigs may cure diabetes
8. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
9. Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus
10. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
11. Discovery Institute Bioethicist Lauds Breakthrough in Stem Cells Research that Eliminates Need for Human Cloning

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...STON,Nov.25/PRNewswire/--BiotechfirmReplikinsLtd.,...8pandemicthroughtheprediction,outbreak,andprogress...emicalanalysisofthevirus.Thenewdatashowsthatthelet...eakof3.7(s.d.4.5)duringthevirus,scurrentoutbreakin...of2.0(s.d.0.1).TheH1N1virus,infectivitycount,howev...
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/--Reportlinker.comannounce...ogue: ,, BrazilBioethanolMarketAnalysisandFore...165503/Brazil-Bioethanol-Market-Analysis-and-Forec...lysisandForecaststo2013 ,, Summary ,, Ther...albioethanolmarketandtheBrazilbioethanolmarketinpa...
(Date:11/24/2009)... The New York investment bank KTA C...U) has agreed an AU$6.7 mil convertible note priva...he private placement was arranged by KTA Capital a... , New York (PRWEB) Novemb... bank KTA Capital, LLC ("KTA Capital") h...
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...edical Systems, Growing Network of Medical Technol...Year of Profitability in 2007., PLEASANTON, Calif...an office in Russia to open a distribution network...lted in the registration of DMS,s,InNovaSound USB ... medical,providers in Russia., (Logo: http://www...
..., Calif., May 16 Immunosyn,Corporation (OTC Bulle...tained exclusive worldwide marketing, sales and di... from its affiliate Argyll Biotechnologies,LLC, ha...ch 31, 2008., For the quarter ended March 31, 200... administrative expenses and $13,393.00 in interes...
..., Calif., May 16 InterMune, Inc.,(Nasdaq: ITMN )...esident and,Chief Financial Officer of InterMune, ...re Conference in New York on May 22, 2008 at 1:30 ...presentation, investors and other,interested parti...terMune,s,corporate website at http://www.intermu...
Other Biology Technology:Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the World's Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound. 2Immunosyn Corporation Files 10-Q 2Immunosyn Corporation Files 10-Q 3
(Date:11/24/2009)...held secrets of the earth,s history locked in its ...y little information on the environments that have...years. Now, a team of researchers from nine instit...e of $10 million dollars by the National Science F... literally. These scientists will drill through th...
(Date:11/23/2009)...ociated strain of the deadly superbug MRSAan infec...ibioticsposes a far greater health threat than pre..., according to a study in the December issue of E...is easily picked up in fitness centers, schools, a...ll burden of MRSA within hospitals, the report fou...
(Date:11/23/2009)...ggests that a common oral bacterium may exacerbate...s et al, "Unique Lipids from a Common Human Bacter...of Enhancing Autoimmunity," appears in the Decembe... . , Multiple sclerosis (MS), a disease where th... affects nearly 1 in 700 people in the United Stat...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 1Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 3Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 4Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 1Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 2Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 3Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 1Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 2
...more than half of children with sore throat, excee...used nonrecommended antibiotics for 27 percent of ...according to a study in the November 9 issue of JA...ounts for 6 percent of visits by children to famil... to background information in the article. The mos...
...e have demonstrated that Langerhans cells in the s...stem to pathogens, instead dampen the skin,s react...potential to significantly alter understanding of ... as psoriasis, lupus and skin cancer. , Dendriti...emely efficient at alerting the immune system to t...
...iated with an increased risk of hypertension in wo...nsumption of sugared or diet colas, according to a...ately 50 million people in the United States have ...cording to background information in the article. ...eart disease, stroke, and congestive heart failure...
Other Biology News:Children overprescribed antibiotics for sore throat 2Langerhans cells regulate immune reactions in the skin 2No link found between caffeine intake and development of hypertension in women 2
Hae III (High Concentration) from Takara Mirus Bio
Sma I (High Concentration) from Takara Mirus Bio
2 ml SmartScan Racks from ABgene
Mouse Anti-beta-III-Tubulin Monoclonal Antibody, Unconjugated, Clone TU-20 from BioVendor Laboratory Medicine, Inc.
Biology Products: